- Home
- KROS vs CCBG Comparison
KROS vs CCBG Comparison
Compare KROS & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- CCBG
- Stock Information
- Founded
- KROS 2015
- CCBG 1895
- Country
- KROS United States
- CCBG United States
- Employees
- KROS N/A
- CCBG N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- CCBG Major Banks
- Sector
- KROS Health Care
- CCBG Finance
- Exchange
- KROS Nasdaq
- CCBG Nasdaq
- Market Cap
- KROS 558.9M
- CCBG 671.1M
- IPO Year
- KROS 2020
- CCBG N/A
- Fundamental
- Price
- KROS $14.68
- CCBG $41.13
- Analyst Decision
- KROS Buy
- CCBG Buy
- Analyst Count
- KROS 13
- CCBG 2
- Target Price
- KROS $20.63
- CCBG $39.00
- AVG Volume (30 Days)
- KROS 487.4K
- CCBG 41.1K
- Earning Date
- KROS 08-06-2025
- CCBG 07-22-2025
- Dividend Yield
- KROS N/A
- CCBG 2.38%
- EPS Growth
- KROS N/A
- CCBG 11.98
- EPS
- KROS 0.11
- CCBG 3.37
- Revenue
- KROS $214,713,000.00
- CCBG $236,037,000.00
- Revenue This Year
- KROS $5,006.76
- CCBG $10.45
- Revenue Next Year
- KROS N/A
- CCBG $3.50
- P/E Ratio
- KROS $132.53
- CCBG $11.98
- Revenue Growth
- KROS 91657.70
- CCBG 6.63
- 52 Week Low
- KROS $9.12
- CCBG $28.11
- 52 Week High
- KROS $72.37
- CCBG $42.00
- Technical
- Relative Strength Index (RSI)
- KROS 64.67
- CCBG 59.31
- Support Level
- KROS $13.26
- CCBG $40.75
- Resistance Level
- KROS $14.68
- CCBG $42.00
- Average True Range (ATR)
- KROS 0.41
- CCBG 1.04
- MACD
- KROS 0.12
- CCBG 0.19
- Stochastic Oscillator
- KROS 89.35
- CCBG 68.62
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.